The Effect of Copper Acetate on p-Dimethylamino-Azobenzene Carcinogenesis in the Rat
1958

The Effect of Copper Acetate on Tumor Development in Rats

Sample size: 110 publication 15 minutes Evidence: moderate

Author Information

Author(s): J. S. Howell

Primary Institution: University of Birmingham

Hypothesis

Does copper acetate inhibit hepatic tumor development induced by p-dimethylaminoazobenzene (DMAB) in rats?

Conclusion

Copper acetate significantly inhibits the development of hepatic tumors in rats treated with DMAB.

Supporting Evidence

  • Copper acetate reduced the incidence of tumors in rats treated with DMAB.
  • Rats receiving copper acetate had less liver damage compared to those receiving DMAB alone.
  • Only one out of sixteen rats treated with copper acetate developed a tumor after 18 months.

Takeaway

This study found that giving copper acetate to rats helps stop them from getting liver tumors caused by a certain chemical.

Methodology

Rats were divided into groups and fed different diets containing DMAB and copper acetate, with regular monitoring for tumor development.

Potential Biases

Potential bias due to the selection of rat strains and dietary conditions.

Limitations

The study was limited to specific strains of rats and the effects may not be generalizable to other populations.

Participant Demographics

Rats aged between 2 and 6 months, with equal numbers of males and females in each group.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication